603139.SH
Shaanxi Kanghui Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 31.81
+1.56%Year over year
Reported trailing growth
- Revenue
- -20.2%
- EBITDA
- —
- EBIT
- -96.2%
- EPS
- —
- Free cash flow
- +79.2%
- Operating cash flow
- +165.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.4%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026